Secondary Prevention
DIAN-TU Gantenerumab Open-Label Extension and Tau NexGen Trials Update
Family Conference 2021
DIAN-TU New Site Outreach and Next Steps
Family Conference 2022
DIAN-TU Overview and Next Steps, Part 2
Family Conference 2020
DIAN-TU Trial Results: Biomarkers, The Power of CSF
Family Conference 2020
How Amyloid Burden Varies Across DIAD Genotypes
Family Conference 2022
Panel Discussion: The State of Alzheimer’s Disease Research
Family Conference 2015
Panel Q&A about DIAN-TU Trial 001 Results
Family Conference 2020
Participating in DIAD Research: Risk, Challenges, and the Way Forward
Family Conference 2017
Prevention Studies in DIAD
Family Conference 2017
The DIAN-TU Trial Overview and Next Steps
Family Conference 2022